Last update 23 Jan 2025
Amura Ltd.

Amura Ltd.

Private Company|
2002
|
< 10
|
www.amura.co.uk

Overview

Related

3
Drugs associated with Amura Ltd.
AM-114
Target
β-lactamase
Mechanism
β-lactamase inhibitors
Active Org.
University of AstonUniversity of Aston
Originator Org.
Amura Ltd.Amura Ltd.
Active Indication
Gram-Negative Bacterial Infections [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
AM-112
Target
β-lactamase
Mechanism
β-lactamase inhibitors
Active Org.
University of AstonUniversity of Aston
Originator Org.
Amura Ltd.Amura Ltd.
Active Indication
Gram-Negative Bacterial Infections [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Melanin-concentrating hormone receptor 1 antagonists (Amura)
Target
MCHR1
Mechanism
MCHR1 inhibitors
Active Org.-
Originator Org.
Amura Ltd.Amura Ltd.
Active Indication-
Inactive Indication
Obesity
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Amura Ltd.
Login to view more data
0 Patents (Medical) associated with Amura Ltd.
Login to view more data
100 Deals associated with Amura Ltd.
Login to view more data
100 Translational Medicine associated with Amura Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
AM-114
 ( β-lactamase )		Bacterial Infections
More
Discontinued
Melanin-concentrating hormone receptor 1 antagonists (Amura)
 ( MCHR1 )		Obesity
More
Discontinued
AM-112
 ( β-lactamase )		Bacterial Infections
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free